Tirzepatide 30mg US
Tirzepatide 30mg US - Image 2

Tirzepatide 30mg US

$381.47

Tirzepatide is a dual incretin receptor agonist that engages GLP-1 and GIP pathways, designed for controlled laboratory and in-vitro research use.
Researchers examine this compound for synergistic effects on metabolic signaling, including glucose regulation, appetite control, and lipid handling in preclinical models.

0.00561 0.00561
0.19293 0.19293
381.47000 381.47000
7.09844 7.09844
381.48907 381.48907
0.85039 0.85039
Category: Tags: , , , Brand:

Description

What is Tirzepatide (Dual GLP-1/GIP Agonist)?

Tirzepatide is a dual incretin receptor agonist that engages GLP-1 and GIP pathways, designed for controlled laboratory and in-vitro research use.
Researchers examine this compound for synergistic effects on metabolic signaling, including glucose regulation, appetite control, and lipid handling in preclinical models.

Research Focus Areas

The molecule is studied for its capacity to modulate post-prandial glucose, insulin dynamics, gastric-emptying kinetics, and energy-balance signaling. Dual-pathway activation enables observation of integrated metabolic responses within a single research model.

Potential Research Benefits

1) Glycemic Regulation Models

  • Increases insulin sensitivity and improves glucose tolerance.

  • Supports β-cell function markers and post-prandial control.

  • Modulates gastric emptying and incretin signaling dynamics.

2) Body-Weight & Energy-Balance Models

  • Promotes appetite control and reduced caloric intake.

  • Explored for enhanced energy-expenditure proxies and fat-mass reduction.

  • Assessed alongside diet/exercise variables for combinational effects.

3) Cardiometabolic Marker Studies

  • Reduction in circulating lipids and triglycerides.

  • Investigated for impacts on hepatic fat proxies and inflammatory markers.

  • Supports vascular-metabolic health modeling via integrated endpoints.

Unit Size: Includes 10 sterile research-use syringes with every vial order (for laboratory handling only; not for bodily introduction).

Cybergen Peptides: Research Use Disclaimer

All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes. These materials are supplied for in-vitro research only (“in glass”) and are not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency. Any form of bodily introduction or therapeutic application is strictly prohibited.

Related products